Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 876-879

  Maloney, Elizabeth M ^a,f   Armien, Blas ^b   Gracia, Fernando ^b   Castillo, Luis ^b   Kruger, Hilary ^c   Levin, Arthur ^c   Levine, Paul H ^c   Kaplan, Jonathan E ^d   Blattner, William A ^e   Giusti, Ruthann M ^a  

^a Epidemiology and Biostatistics Program   (United States)

^b Centro Conmemorativo Gorgas   (Panama)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CULTURAL FACTOR; EDUCATION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PANAMA; PRIORITY JOURNAL; PROSTITUTION; RISK FACTOR; SCHOOL CHILD; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMICS;

ADOLESCENT; ADULT; CHILD; FEMALE; HTLV-II INFECTIONS; HUMANS; INDIANS, CENTRAL AMERICAN; MALE; PANAMA; PROSTITUTION; RISK FACTORS; RISK-TAKING; SEX FACTORS; SEXUAL BEHAVIOR;

EID: 0032827927     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314916     Document Type: Article

References (8)

1. 1. Vitek CR, Gracia FI, Giusti R, et al. Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama. J Infect Dis 1995;171:1022-6.
2. 2. Hjelle B, Cyrus S, Swenson SG. Evidence for sexual transmission of human T lymphotropic virus type II. Ann Intern Med 1992;116:90-1.
3. 3. Vallejo A, Borge T, Varela JM, Casado C, Garcia-Saiz A. Evidence for sexual transmission of HTLV-II in Spain. Int J Cancer 1995;60;285-6.
4. 4. Sanchez-Martinez, Schmid DS, Whittington W, et al. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis 1991;164:1196-9.
5. 5. Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, USA. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:89-96.
6. 6. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous blood donors and persons in clinics for sexually transmitted diseases. N Engl J Med 1992;326:375-80.
7. 7. Schreiber GB, Murphy EL, Horton JA, et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: The Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:263-71.
8. 8. Kaplan JE, Khabbaz RF, Murphy EL, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:193-201.